Market Introduction
The clinical trial is an investigation study that defines whether a medical approach, therapy, or device is effective, safe, and useful for human applications. These studies help to find which therapeutic approaches experiment is best for certain diseases. Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance.
Market Overview and Dynamics
The North America clinical trial supplies market is expected to reach US$ 1,364.10 Mn by 2027 from US$ 758.95 Mn in 2019; it is estimated to grow at a CAGR of 7.7% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as increasing R&D expenditures in the pharmaceutical & biopharmaceutical companies and increase in the number of clinical trials. However, challenges for clinical trials due to negative impact of COVID-19 pandemic is expected to restraint the growth of the market during the forecast years.
Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance. Research and development (R&D) is a significant and essential part of the business of pharmaceuticals and biopharmaceuticals companies. R&D spending by biopharmaceuticals companies has increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of these companies has increased from US$ 59.6 billion in 2015 to US$ 79.6 billion in 2018. Drug development and discovery is a time-consuming and expensive process. The process stages range from early detection or design to development and regulatory approval, and the entire process can take more than 10–15 years. Throughout the drug development phase, various testing services are required to check the quality and efficacy of the drug substance. Several manufacturers are investing in clinical supplies in the pharmaceutical industry. Therefore, the pharmaceutical and biotech companies are dependent on the supplies for the services to the clinical trials, which is expected to drive the market. Also, advanced health care infrastructure and presence of multinational pharmaceutical and biotechnology companies that carry out clinical trials in North America will bolster the market growth.
Key Market Segments
Based on product & service, the North America clinical trial supplies market is segmented into manufacturing, packaging & labelling, and logistics & distribution. The logistics & distribution segment held the largest share of the market in 2019; the segment is anticipated to register the highest CAGR in the market during the forecast period.
In terms of stage, the North America clinical trial supplies market is segmented into phase I, phase II, phase III, and bioequivalence studies. The phase III segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
Based on drug type, the North America clinical trial supplies market is segmented into small-molecule drugs and biologic drugs. The small-molecule drugs segment held the largest share of the market in 2019, whereas the biologic drugs segment is estimated to register the highest CAGR in the market during the forecast period.
Based on application, the North America clinical trial supplies market has been segmented into oncology, cardiovascular diseases, neurological disorders, respiratory disorders, and others. The oncology segment held the largest share of the market in 2019 and is estimated to register the highest CAGR during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the North America clinical trial supplies market are the Canada Foundation of Innovation (CFI), Pharmaceutical Research and Manufacturers of America (PhRMA) and Association of Clinical Research Organizations (ACRO).
Reasons to buy the report
NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION
By Product & Service
By Stage
By Drug Type
By Application
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 758.95 Million |
| Market Size by 2027 | US$ 1,364.10 Million |
| CAGR (2020 - 2027) | 7.7% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product & Service
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Clinical Trials Supplies Market is valued at US$ 758.95 Million in 2019, it is projected to reach US$ 1,364.10 Million by 2027.
As per our report North America Clinical Trials Supplies Market, the market size is valued at US$ 758.95 Million in 2019, projecting it to reach US$ 1,364.10 Million by 2027. This translates to a CAGR of approximately 7.7% during the forecast period.
The North America Clinical Trials Supplies Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Clinical Trials Supplies Market report:
The North America Clinical Trials Supplies Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Clinical Trials Supplies Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Clinical Trials Supplies Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Clinical Trials Supplies Market
